TEX46 and cancer: By integrating multi-omics data from cell lines, single-cell RNA-seq, pan-cancer datasets, and immunotherapy cohorts, we identified three distinct pan-cancer subtypes based on m6A-TEX crosstalk, each with significant prognostic implications for patient survival and immunotherapy response.